State Board of Administration of Florida Retirement System’s Galectin Therapeutics GALT Stock Holding History

State Board of Administration of Florida Retirement System’s Portfolio GALT Stock Details GALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-18,318	Closed	-$61K	–	2438
2015 Q1	$61K	Hold	18,318	–	–	﹤0.01%	2448
2014 Q4	$64K	Hold	18,318	–	–	﹤0.01%	2481
2014 Q3	$92K	Hold	18,318	–	–	﹤0.01%	2462
2014 Q2	$253K	Buy	+18,318	New	+$228K	﹤0.01%	2343

Other funds holding GALT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Board of Administration of Florida Retirement System's GALT Position: Q2 2015 in Review

State Board of Administration of Florida Retirement System sold out of Galectin Therapeutics (GALT) in Q2 2015, closing a stake of 18,318 shares — an estimated $61K sold.

State Board of Administration of Florida Retirement System first reported a position in GALT in Q2 2014 and held it in 4 quarters. The position peaked at $253K in Q2 2014. 58 funds tracked by Wall St. Rank hold GALT as of Q2 2015.

State Board of Administration of Florida Retirement System reported no remaining Galectin Therapeutics position as of Q2 2015 after selling out during the quarter.
State Board of Administration of Florida Retirement System sold 18,318 Galectin Therapeutics shares in Q2 2015, an estimated $61K.
State Board of Administration of Florida Retirement System first reported a position in Galectin Therapeutics in Q2 2014 and held it in 4 quarters.
State Board of Administration of Florida Retirement System's Galectin Therapeutics position peaked at $253K in Q2 2014.
58 funds tracked by Wall St. Rank held Galectin Therapeutics as of Q2 2015.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2015, filed 29 Jul 2015.